Protalix BioTherapeutics stock price
프로탈릭스 바이오테라퓨틱스NYSEAMERICAN:PLX · NYSE Amex · Healthcare · sector #14Protalix BioTherapeutics's chart data is dated 2026-10-09. Recorded technical signals: VCP. There are 6 published signal records.
Protalix BioTherapeutics last closed at $2.78 (+2.96%) on 2026-10-09. Signals today: VCP. Listed on NYSE Amex. Trailing 12 months PER is 12.1×. Its overall grade ranks 72 of 736 stocks in Healthcare.
About this company
Protalix BioTherapeutics last closed at $2.78 (+2.96%) on 2026-10-09. Signals today: VCP. Listed on NYSE Amex.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 72/736
Valuation grade C
Related stocks
- Chiesi FarmaceuticiCustomer
브라질 파브라자임(Fabrazyme) 대체 효소치료제 Elfabrio의 상업화 파트너
- PfizerCompetitor
희귀질환·바이오의약품 시장에서 경쟁하는 대형 제약사
- SanofiCompetitor
희귀질환 및 효소대체요법(ERT) 분야의 주요 글로벌 경쟁사
About Protalix BioTherapeutics
- What technical signals does Protalix BioTherapeutics (PLX) have?
- Protalix BioTherapeutics current technical signals: VCP.
- Is Protalix BioTherapeutics a cup-and-handle pattern?
- No. Protalix BioTherapeutics has no valid Cup signal right now.
- What published figures are available for Protalix BioTherapeutics?
- Market cap: $223.57M. Trailing 12 months PER: 12.1×. Latest quarter PBR: 3.21×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-10 dataset
Turn what you saw on this name into a strategy
Ask Q about Protalix BioTherapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.